General Range
FORLIC-CV 625
Price on request/100 · MOQ 100 boxes
FORLIC-CV 625 Tablets by Fortune Labs contain Amoxycillin and Potassium Clavulanate, a prescription antibiotic combination used for treating selected bacterial infections caused by susceptible microorganisms. Amoxycillin is a penicillin-class antibiotic that inhibits bacterial cell wall synthesis, while Potassium Clavulanate blocks certain beta-lactamase enzymes responsible for antibiotic resistance. FORLIC-CV 625 may be prescribed for selected respiratory tract, ear, sinus, urinary tract, dental and skin infections when clinically appropriate. Available in convenient blister strip packaging of 10 × 10 tablets, the formulation provides an oral antibiotic treatment option for eligible patients. FORLIC-CV 625 should be taken according to a registered medical practitioner's prescription, considering bacterial susceptibility, penicillin allergy, kidney function, potential adverse effects and recommended treatment duration. Unnecessary antibiotic use should be avoided.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Amoxycillin & Potassium Clavulanate Tablets I.P.
- Packaging Type
- Tablet Blister Strips with Printed Carton Box
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- May treat certain bacterial infections affecting the respiratory system.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
